Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: a review of the current clinical evidence

Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: a review of the current clinical evidence

Sagari Bette, Danielle S Shpiner, Carlos Singer, Henry Moore Department of Neurology, Division of Parkinson’s Disease and Movement Disorders, University of Miami – Miller School of Medicine, Miami, FL, USA Abstract: Safinamide (Xadago®) is a novel medication with both d...

Full description

Bibliographic Details
Main Authors: Bette S, Shpiner DS, Singer C, Moore H
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Parkinson's disease
safinamide
MAO-B inhibitor
motor fluctuations
dyskinesia
Online Access:https://www.dovepress.com/safinamide-in-the-management-of-patients-with-parkinsonrsquos-disease--peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/safinamide-in-the-management-of-patients-with-parkinsonrsquos-disease--peer-reviewed-article-TCRM

Similar Items